SP70 is a potential biomarker to identify gastric fundic gland neoplasms.

Abstract

BACKGROUND:

Gastric neoplasms with fundic gland differentiation include oxyntic gland adenomas (OGAs) and gastric adenocarcinomas of fundic gland type (GA-FGs). Due to their well-differentiated and similar morphology with normal fundic glands, it is usually challenging to identify these lesions in pathological diagnosis, especially in biopsy specimens. This study aims to explore and verify the potential role of a newly developed monoclonal antibody (McAb) NJ001 (SP70) in differentiating fundic neoplasms from non-neoplastic fundic gland lesions.

METHODS:

Twenty-three cases of histological confirmed gastric fundic gland neoplasms were obtained, including 12 cases of OGAs and 11 of GA-FGs. Fifty cases of fundic gland polyps (FGPs) were taken as the control group. Six cases of well-differentiated gastric neuroendocrine tumors (NETs) (easily misdiagnosed) were also obtained. Key clinicopathological information was collected. SP70 immunostaining was performed (with para-tumor normal fundic glands as internal control). The positive intensity and staining pattern of SP70 were analyzed and compared.

RESULTS:

In normal gastric mucosa, SP70 was strongly and diffusely stained on the cytoplasm in fundic glands, but not in the foveolar epithelium. Therefore, a zonal distribution of SP70 was observed in normal mucosa. FGPs (50/50, 100%) shared a similar expression pattern with normal fundic glands. In fundic gland neoplasms, a significant down-expression of SP70 was observed in both OGAs and GA-FGs. The positive rate of SP70 in fundic gland neoplasms (6/23, 26.1%) was significantly lower than that in FGPs (100%) (P<0.0001). There was no difference in SP70 expression between OGAs (3/12, 25.0%) and GA-FGs (3/11, 27.2%) group (P>0.05). In these 6 NET cases, SP70 was weak to moderate intensity in the majority of tumor cells (with a different expression pattern).

CONCLUSION:

Down-expression of SP70 is a specific feature to fundic gland neoplasms including OGAs and GA-FGs. Therefore, SP70 can serve as a potential biomarker in the identification and differential diagnosis of fundic gland neoplasms.

• Authors: Rongkui Luo, Wen Huang, Lingli Chen, Yalan Liu, Lei Xu, Xiaolei Zhang, Chen Xu, Yingyong Hou
• Journal: World journal of surgical oncology (World J Surg Oncol) Vol. 20 Issue 1 Pg. 132 (Apr 25 2022) ISSN: 1477-7819 [Electronic] England
• PMID: 35468832 (Publication Type: Journal Article)
• Copyright: © 2022. The Author(s).

Chemical References

• Biomarkers

Topics

• Adenomatous Polyps
• Biomarkers
• Gastric Fundus (pathology)
• Gastric Mucosa (pathology)
• Humans
• Polyps
• Stomach Neoplasms (diagnosis, pathology)